Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ EGLN1/PHD2 Antibody Blocking Peptide
SDP

Catalog No. NB1002219E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB1002219E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB1002219E Supplier Novus Biologicals™ Supplier No. NB1002219PEP
Only null left
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A peptide to EGLN1. The EGLN1/PHD2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 54583
Species Mouse
Content And Storage Store at -80 C. Avoid freeze-thaw cycles.
Formulation Peptide dissolved in dH2O. Contains no BSA.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NB100-2219. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias C1orf12HPH2, EC 1.14.11, EC 1.14.11.-, ECYT3, egl nine homolog 1, egl nine homolog 1 (C. elegans), egl nine-like protein 1, HIF prolyl hydroxylase 2, HIF-PH2, HIFPH2 EGL nine (C.elegans) homolog 1, HIF-prolyl hydroxylase 2, HPH-2, Hypoxia-inducible factor prolyl hydroxylase 2, PHD2SM20, Prolyl hydroxylase domain-containing protein 2, SM-20, zinc finger MYND domain-containing protein 6, ZMYND6DKFZp761F179
Gene Symbol EGLN1
Product Type EGLN1/PHD2
Quantity 0.05 mg
Regulatory Status RUO - research use only
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.